AMS - Pediatric Infectious Diseases: Pathogens in the News; UTIs; Kawasaki Disease (Download)

Sale!

Original price was: $99.00.Current price is: $49.00.


Topics and Objectives


Title: Pediatric Infectious Diseases: Pathogens in the News; UTIs; Kawasaki Disease
Faculty: Stephen C. Eppes, M.D., F.A.A.P. and Michael J. Muszynski, M.D., F.A.A.P.

Original Release Date: July 1, 2016 Review Date: July 1, 2017  Expiration Date: July 1, 2019

TOPIC 1: Pathogens in the News: What Do They Mean For You.
Upon completion of this session and using the guidelines from the CDC, the participant should beable to: GL, COMP

  1. Recognize the current epidemiology of highly contagious viral or other infectious diseases that are of most immediate public health concern.
  2. Identify key clinical manifestations, as documented by the CDC guidelines, of these diseases.
  3. Plan for necessary precautions for newly identified viruses as developed and recommended by the CDC protocols and guidelines.
  4. Employ CDC recommended actions to contact Hospital, Local, State and Federal Health Officials as appropriate or mandated.

TOPIC 2: Urinary Tract Infections.
Upon completion of this session, using the evidence-based guidelines from the AAP, the participant should be able to: EBM, GL, COMP

  1. Determine the clinical situations in which urinary tract infections should be considered.
  2. Appraise diagnostic methods for urinary tract infection, characterize their reliability and application, and recognize their limitations.
  3. Employ the most appropriate treatment options.
  4. Assess the controversies concerning follow-up and prevention strategies.

TOPIC 3: Kawasaki Disease.
Upon completion of this session, the participant should be able to: COMP

  1. Recognize clinical/laboratory manifestations of Kawasaki disease.
  2. Evaluate and manage patients according to AAP/AHA guidelines.
  3. Recognize the potential for coronary complications.


StreamingINCLUDED
Total Cost: $

    Expiration Date: July 1, 2019

    Title: Pediatric Infectious Diseases: Pathogens in the News; UTIs; Kawasaki Disease
    Faculty: Stephen C. Eppes, M.D., F.A.A.P. and Michael J. Muszynski, M.D., F.A.A.P.

    Original Release Date: July 1, 2016 Review Date: July 1, 2017  Expiration Date: July 1, 2019

    TOPIC 1: Pathogens in the News: What Do They Mean For You.
    Upon completion of this session and using the guidelines from the CDC, the participant should beable to: GL, COMP

    1. Recognize the current epidemiology of highly contagious viral or other infectious diseases that are of most immediate public health concern.
    2. Identify key clinical manifestations, as documented by the CDC guidelines, of these diseases.
    3. Plan for necessary precautions for newly identified viruses as developed and recommended by the CDC protocols and guidelines.
    4. Employ CDC recommended actions to contact Hospital, Local, State and Federal Health Officials as appropriate or mandated.

    TOPIC 2: Urinary Tract Infections.
    Upon completion of this session, using the evidence-based guidelines from the AAP, the participant should be able to: EBM, GL, COMP

    1. Determine the clinical situations in which urinary tract infections should be considered.
    2. Appraise diagnostic methods for urinary tract infection, characterize their reliability and application, and recognize their limitations.
    3. Employ the most appropriate treatment options.
    4. Assess the controversies concerning follow-up and prevention strategies.

    TOPIC 3: Kawasaki Disease.
    Upon completion of this session, the participant should be able to: COMP

    1. Recognize clinical/laboratory manifestations of Kawasaki disease.
    2. Evaluate and manage patients according to AAP/AHA guidelines.
    3. Recognize the potential for coronary complications.
    When you add a gift card to your CME purchase from American Medical Seminars:
    • The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
    • This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.

    Related products